Keppra (Levetiracetam) versus Phenytoin: Differences in Epilepsy Treatment
Keppra, known generically as levetiracetam, and phenytoin are both anti-epileptic drugs used to treat seizure disorders, but they differ in their mechanisms of action, side effect profiles, and common uses.
How do Keppra and Phenytoin work differently?
Levetiracetam's precise mechanism of action is not fully understood, but it is thought to modulate synaptic vesicle protein 2A (SV2A) in the brain, which is involved in regulating neurotransmitter release [1]. Phenytoin, on the other hand, works by blocking voltage-gated sodium channels in neurons. This action stabilizes neuronal membranes and prevents the rapid, repetitive firing that characterizes seizures [2].
What are the typical side effects of Keppra?
Common side effects associated with levetiracetam include drowsiness, dizziness, weakness, and behavioral changes such as aggression, agitation, or mood disturbances [1].
What are the common side effects of Phenytoin?
Phenytoin can cause a range of side effects, including dizziness, unsteadiness, confusion, nausea, vomiting, and gum overgrowth (gingival hyperplasia). More serious side effects can include skin rashes, blood disorders, and damage to nerves or brain tissue [2].
When are Keppra and Phenytoin typically prescribed?
Levetiracetam is often used as a broad-spectrum anti-epileptic medication for various seizure types, including partial-onset seizures, myoclonic seizures, and generalized tonic-clonic seizures, and it is frequently used in both adults and children [1]. Phenytoin is primarily used for the treatment of generalized tonic-clonic seizures and complex partial seizures in adults and children. It is also used to prevent and treat seizures that occur during or after brain surgery [2].
Are there drugs similar to Keppra or Phenytoin?
Other anti-epileptic drugs with similar uses or mechanisms exist. For instance, other sodium channel blockers are available for seizure treatment. Similarly, there are other medications that target synaptic vesicle proteins or have other mechanisms to control neuronal excitability.
What is the typical dosage for Keppra and Phenytoin?
Dosages for both levetiracetam and phenytoin vary based on the individual patient's age, weight, seizure type, and response to treatment. They are typically initiated at a low dose and gradually increased [1][2].
How do Keppra and Phenytoin compare in terms of drug interactions?
Phenytoin is known to have significant interactions with many other medications, as it is metabolized by liver enzymes and can affect their activity. Levetiracetam, in contrast, has fewer known significant drug interactions [1][2].
Are there any specific patient populations for whom one drug is preferred?
Due to its tolerability and fewer drug interactions, levetiracetam is often a preferred choice, particularly in patients taking multiple medications or those with potential for hepatic impairment. Phenytoin's use may be more carefully considered in patients with certain comorbidities or those on other interacting drugs [1][2].
What is the patent status of Keppra and Phenytoin?
Phenytoin has been available for many decades, and its original patents have long expired. Levetiracetam (Keppra) was patented by UCB Pharma. The original patent for levetiracetam expired, allowing for the development of generic versions of the drug [3]. Information on specific patent expiry dates and any associated litigation or extensions can be found through resources like DrugPatentWatch.com [3].
What are the costs associated with Keppra and Phenytoin?
The cost of treatment can vary significantly. Generic versions of levetiracetam are generally available and may be more affordable than the brand-name Keppra. Phenytoin is also widely available as a generic medication. Costs are influenced by factors such as insurance coverage, pharmacy, and dosage [1][2].
---
1. Levetiracetam. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/drug-information/levetiracetam
2. Phenytoin. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/drug-information/phenytoin
3. DrugPatentWatch.com. https://drugpatentwatch.com/